Brief: Biohit Upgrades 2022 Outlook, Says Prelim H1 EBIT Up At EUR 1.3 Mln

Biohit Oyj

03/08/2022 08:13

Aug 3 (Reuters) - Biohit Oyj  BIOBV.HE :
    * NOW ESTIMATES ITS EBIT TO BE POSITIVE IN 2022
    * BEFORE, COMPANY ESTIMATED ITS 2022 PROFITABILITY TO
IMPROVE
COMPARING WITH 2021
    * REVENUE ROSE APPROXIMATELY TO 6.1 MILLION EUROS IN FIRST
HALF OF
2022 FROM 4.0 MILLION EUROS IN H1/2021.
    * H1 OPERATIVE EBITDA INCREASED APPROXIMATELY TO 1.7 MILLION
EUR
FROM -0.2 MILLION EUR
    * H1 EBIT UP APPROXIMATELY TO 1.3 MILLION EUR FROM -1.2
MILLION
EUR

Source text for Eikon:  ID:nWkr19N2ZS 
Further company coverage:  BIOBV.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))